# Cell Therapy Limited

## Details

- **Company number:** [06970743](https://find-and-update.company-information.service.gov.uk/company/06970743)
- **Status:** Active
- **Type:** Private Limited Company
- **Incorporated:** 23 Jul 2009
- **Registered office:** CELIXIR HOUSE STRATFORD-UPON-AVON BUSINESS AND TECHNOLOGY PARK, INNOVATION WAY, STRATFORD-UPON-AVON, CV37 7GZ
- **Nature of business:** [72190](/sic/72190) Other research and experimental development on natural sciences and engineering
- **Corporate group:** [Cardiogeni PLC](/group/30983) (4 companies)




## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Trevor Ajan Reginald | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 12 Apr 2017 |
| Dr Mubasher Shiekh | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 12 Apr 2017 |
| Sir Martin John Evans | ownership-of-shares-25-to-50-percent, voting-rights-25-to-50-percent | 6 Apr 2016 | 12 Apr 2017 |
| Celixir Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 12 Apr 2017 | 6 Jan 2025 |
| Cardiogeni Plc | significant-influence-or-control, significant-influence-or-control-as-firm | 6 Jan 2025 |  |



## Accounts

| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2025 | -£3,779,356 | £29,530 | 2 |
| 31 Mar 2024 | -£10,682,911 | £153,090 | 3 |
| 31 Mar 2023 | -£10,178,342 | £285,158 | 6 |
| 31 Mar 2022 | -£10,092,009 | £263,058 | 11 |
| 31 Jul 2013 | -£376,025 | £32,228 | - |
| 31 Jul 2012 | -£81,276 | £168,987 | - |
| 31 Jul 2011 | -£15,673 | - | - |
| 31 Jul 2010 | -£10,170 | £74,974 | - |



## Owned by

Cell Therapy Limited → [Cardiogeni PLC](/company/10541091)